PharmaShots | Incisive News in 3 Shots

Subscribe Now

paratek pharmaceuticals

Paratek Pharmaceuticals to Acquire Optinose for ~$330M, Expanding its Commercial Portfolio

Paratek Pharmaceuticals to Acquire Optinose for ~$330M, Expanding its Commercial Portfolio

March 21, 2025

Paratek Pharmaceuticals Reports Topline Results from P-IIb Study of Nuzyra (Omadacycline) for Nontuberculous Mycobacterial Abscessus Pulmonary Disease

Paratek Pharmaceuticals Reports Topline Results from P-IIb Study of Nuzyra (Omadacycline) for Nontuberculous Mycobacterial Abscess...

November 11, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us